X
Menu

+7 495 640-17-71
info@dna-technology.com

Search

News

Important news

“DNA-Technology” has completed the quality assessment study of SARS-CoV-2 molecular detection coordinated by Quality Control for Molecular Diagnostics (QCMD), UK. The Panel  Composition included Alpha, Beta SARS-CoV-2 Variants, etc. The correct result was obtained in 100% of cases.

02.11.2021

First outbreak of the Candida auris, type of yeast or fungi, has been reported recently in the Texas and Washington, USA (source). This fungus is not dangerous for the people with strong immune system, but can be a big problem for those with the impaired immunity – people with chronic or opportunistic diseases.

26.07.2021

“DNA-Technology” has completed the quality assessment study of SARS-CoV-2 molecular detection coordinated by Quality Control for Molecular Diagnostics (QCMD), UK. As the only Russian participant, “DNA-Technology” entered the target group and received an International Certificate confirming the quality of products: during quality assessment study a complete technological process chain was tested, including equipment and kits for RNA extraction and SARS-CoV-2 detection. The correct result was obtained in 100% of cases. Read the QCMD report.

23.12.2020

All news

Dear colleagues!
Visit our stand at Medica 2018: Hall 3, Stand E5. Ask for meeting: sales@dna-technology.ru

15.09.2018

Dear colleagues!
Visit our stand at XXVI European Congress of Perinatal Medicine. Ask for meeting: sales@dna-technology.ru

27.08.2018

Страницы